advertisement
11.3.4 Betablocker (6)
Showing records 1 to 6
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker52024 Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combina
Araie M; Yamazaki Y; Sugiyama K; Kuwayama Y; Tanihara H
Nippon Ganka Gakkai Zasshi 2012; 116: 955-966
51718 Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro
Seibold LK; Ammar DA; Kahook MY
Current Eye Research 2013; 38: 70-74
51950 Prostaglandin Analogs and Timolol-Fixed Versus Unfixed Combinations or Monotherapy for Open-Angle Glaucoma: A Systematic Review and Meta-Analysis
Quaranta L; Biagioli E; Riva I; Rulli E; Poli D; Katsanos A; Floriani I
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 382-389
51781 Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses
Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
Journal of Controlled Release 2013; 165: 82-89
51890 Extended Release of Timolol from Nanoparticle-Loaded Fornix Insert for Glaucoma Therapy
Jung HJ; Chauhan A
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 229-235
51801 Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma
Schmier JK; Covert DW; Lau EC
Clinical Drug Investigation 2012; 32: 835-842